Racial and Ethnic Differences in Graft Loss Among Female Liver Transplant Recipients

• DOI: 10.1016/j.transproceed.2018.02.059
• Publication Date: 2018-06-12T12:31:12Z
• Authors: S. Dave; J.L. Dodge; N.A. Terrault; M. Sarkar
• Keywords: Adult; Aging; Clinical Sciences; Immunology; 610; Clinical sciences; Medical and Health Sciences; White People; Cohort Studies; 03 medical and health sciences; 0302 clinical medicine; Clinical Research; 616; Ethnicity; Humans; Minority Health; Registries; 10. No inequality; Aged; Proportional Hazards Models; Retrospective Studies; Transplantation; Biomedical and Clinical Sciences; Liver Disease; Graft Survival; Organ Transplantation; Hispanic or Latino; Middle Aged; Transplant Recipients; Liver Transplantation; 3. Good health; Health Disparities; Black or African American; Women's Health; Female; Digestive Diseases; 6.4 Surgery

Racial differences in post-liver transplantation (LT) outcomes are identified in predominantly male cohorts. Despite known sex differences in a spectrum of liver-related outcomes, it is not known how race influences graft outcomes in women.Using the Scientific Registry of Transplant Recipients, we examined race and ethnicity and graft loss (death or retransplant) in women transplanted from 2002 to 2012. Covariates included recipient and donor characteristics, socioeconomics, and medical comorbidities.The eligible cohort (n = 15,860) included 11,051 Caucasians, 2171 Hispanics, 1876 African Americans (AAs), and 762 Asian women with median follow-up of 3.1 years. Five-year graft survival was lower in AA women (60%) compared with Caucasians (71%), Hispanics (70%), and Asians (73%) (P < .001). Graft loss was 45% higher among AA women <40 years at transplant compared with AA women aged 50 to 59 (hazard ratio 1.45, 95% confidence interval 1.17-1.81) and aged 60 to 69 years (hazard ratio 1.33, 95% confidence interval 1.03-1.71), and risk increased after age 60 among Caucasians (P < .001 for race-age interactions). Increased graft loss among young AA women was limited to the first 2 years post-LT (P = .002).Younger AA women are at particularly high risk for graft loss, which predominates in the first 2 years post-LT. Prospective studies of immunosuppression adherence and pharmacokinetics, particularly in relation to patient age, may help to explain the mechanisms underlying the higher rates of graft loss in younger AA women.